NERV Minerva Neurosciences, Inc - Common Stock

NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗
$4,39
Fiyat · May 20, 2026
Temel veriler itibarıyla May 5, 2026

NERV Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

Fiyat
$4.39
Piyasa Değeri
$174M
P/E (TTM)
-0.1
EPS (TTM)
$-34.67
Gelir (TTM)
$0
Temettü Verimi
ROE
339.5%
D/E Borç/Özsermaye
52 Haftlık Aralık
$1 – $12

NERV Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Gelir ve Net Gelir $0
7-point trend, +0.00
2017-12-31 2024-12-31
Hisse Başına Kâr $-34.67
7-point trend, -1774.1%
2019-12-31 2025-12-31
Serbest Nakit Akışı
2017-12-31 2017-12-31
Marjlar

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik
5 Yıllık trend
NERV
Akran Ortalaması
P/E (TTM)
5-point trend, +83.1%
-0.1
1.7
P/B (F/D)
5-point trend, -105.3%
-1.2
2.8

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik
5 Yıllık trend
NERV
Akran Ortalaması
ROA
5-point trend, -1297.5%
-434.3%
-33.5%
ROE
5-point trend, +748.5%
339.5%
-60.2%

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik
5 Yıllık trend
NERV
Akran Ortalaması
Current Ratio (Cari Oran)
5-point trend, +45.5%
36.3
6.3
Quick Ratio (Cari Oran)
5-point trend, +47.4%
35.9

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik
5 Yıllık trend
NERV
Akran Ortalaması

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik
5 Yıllık trend
NERV
Akran Ortalaması
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))
5-point trend, -270.8%
$-34.67

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik
5 Yıllık trend
NERV
Akran Ortalaması

NERV Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

AL 9 analist
  • Güçlü Al 2 22,2%
  • Al 4 44,4%
  • Tut 3 33,3%
  • Sat 0 0,0%
  • Güçlü Sat 0 0,0%

12 Aylık Fiyat Hedefi

3 analist · 2026-05-20
Medyan hedef $7.50 +70,8%
Ortalama hedef $9.50 +116,4%

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Ort. Sürpriz
0.24%
Dönem EPS Gerçek EPS Tahmin Sürpriz
31 Mart 2026 $-0.17 $-0.13 -0.04%
31 Aralık 2025 $-0.64 $-0.31 -0.33%
30 Haziran 2025 $-0.43 $-0.92 0.49%
31 Mart 2025 $-0.50 $-1.09 0.59%
31 Aralık 2024 $-0.56 $-1.07 0.51%

Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı

Hisse Sembolü Piyasa Değeri P/E Gelir YoY Net Kar Marjı ROE Brüt Kar Marjı
NERV $174M -0.1 339.5%
RNA $10.91B -14.5 72.1% -3650.4% -47.5%
WHWK $114M -7.3 -72.5% -288.3% -13.4%
IKT $270M -4.2 111.0% -1299.0% -38.2%
VYGR $232M -1.9 -49.5% -296.5% -54.4%
BDTX $139M 6.2 31.9% 18.3%
KROS $398M 8.9 35.7% 17.2%
UNCY $128M -3.5 -29.0% -113.9%
NKTX $131M -1.3 -31.1%
CRBU $151M -1.0 11.7% -1327.4% -102.8%
ANIK $133M -12.6 -5.9% -9.6% -7.5% 56.6%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Gelir Tablosu 14
NERV için Yıllık Gelir Tablosu verileri
Metrik Eğilim 202520242023202220212020201920182017
Revenue 7-point trend, +0.00 · $0 $0 $0 · $41M $0 $0 $0
R&D Expense 9-point trend, -81.0% $6M $12M $13M $15M $32M $22M $58M $35M $30M
SG&A Expense 9-point trend, -14.4% $9M $10M $10M $11M $13M $17M $18M $17M $11M
Operating Expenses 9-point trend, -63.3% $15M $22M $23M $25M $45M $39M $76M $52M $41M
Operating Income 9-point trend, +63.3% $-15M $-22M $-23M $-25M $-45M $2M $-76M $-52M $-41M
Interest Income 9-point trend, +0.7% $948.1K $1M $1M $556.9K $16.5K $161.2K $1M $2M $941.8K
Pretax Income 6-point trend, +21.5% · · · $-32M $-52M $2M $-74M $-50M $-41M
Income Tax 4-point trend, +80.8% · · · · $-2M · $-2M $0 $-9M
Net Income 9-point trend, -830.8% $-293M $1M $-30M $-32M $-50M $2M $-72M $-50M $-32M
EPS (Basic) 7-point trend, -1774.1% $-34.67 $0.19 $-4.61 $-6.01 $-9.35 $0.05 $-1.85 · ·
EPS (Diluted) 7-point trend, -1774.1% $-34.67 $0.19 $-4.61 $-6.01 $-9.35 $0.05 $-1.85 · ·
Shares (Basic) 7-point trend, -78.3% 8,463,581 7,568,981 6,506,372 5,340,194 5,340,196 40,823,717 39,014,302 · ·
Shares (Diluted) 7-point trend, -78.3% 8,463,581 7,573,763 6,506,372 5,340,194 5,340,196 40,916,871 39,014,302 · ·
EBITDA 6-point trend, +63.3% $-15M · · · $-45M $2M $-76M $-52M $-41M
Bilanço 22
NERV için Yıllık Bilanço verileri
Metrik Eğilim 202520242023202220212020201920182017
Cash & Equivalents 9-point trend, +215.9% $82M $21M $41M $36M $61M $25M $21M $50M $26M
Short-term Investments 3-point trend, -76.1% · · · · · · $24M $38M $102M
Prepaid Expense 9-point trend, -46.3% $697.7K $806.9K $989.9K $848.1K $1M $2M $1M $2M $1M
Current Assets 9-point trend, -35.9% $83M $22M $42M $40M $62M $27M $47M $90M $130M
PP&E (Net) 7-point trend, -100.0% $0 $5.4K $10.9K $16.3K · · $16.0K $33.5K $50.9K
Goodwill Flat — no change across 9 periods $15M $15M $15M $15M $15M $15M $15M $15M $15M
Intangibles 4-point trend, -55.6% · · · · · $15M $15M $34M $34M
Other Non-current Assets Flat — no change across 4 periods · · · · · $14.8K $14.8K $14.8K $14.8K
Total Assets 9-point trend, -46.7% $98M $37M $57M $55M $77M $58M $77M $139M $184M
Accounts Payable 9-point trend, -55.4% $639.7K $2M $2M $969.7K $2M $995.6K $2M $2M $1M
Short-term Debt · · · · · · · · $4M
Current Liabilities 9-point trend, -66.5% $2M $3M $3M $1M $3M $3M $7M $4M $7M
Capital Leases · · · · · · $111.2K · ·
Deferred Tax 4-point trend, -55.6% · · · · · $2M $2M $4M $4M
Other Non-current Liabilities 2-point trend, -3.0% · · · · · · · $29.0K $29.9K
Total Liabilities 9-point trend, +348.7% $234M $63M $85M $75M $69M $5M $50M $49M $52M
Total Debt · · · · · · · · $4M
Common Stock 9-point trend, +11.7% $4.3K $699 $699 $534 $534 $4.3K $3.9K $3.9K $3.9K
Retained Earnings 9-point trend, -319.0% $-689M $-395M $-397M $-367M $-335M $-285M $-287M $-215M $-164M
Stockholders' Equity 9-point trend, -207.0% $-141M $-26M $-28M $-20M $8M $53M $28M $90M $132M
Liabilities + Equity 9-point trend, -46.7% $98M $37M $57M $55M $77M $58M $77M $139M $184M
Shares Outstanding 9-point trend, +11.7% 43,274,398 6,993,406 6,993,406 5,340,193 5,340,196 5,340,196 39,084,121 38,937,971 38,749,343
Nakit Akışı 12
NERV için Yıllık Nakit Akışı verileri
Metrik Eğilim 202520242023202220212020201920182017
D&A 7-point trend, -50.9% $5.4K $5.4K $5.4K · · $16.0K $17.5K $17.5K $11.1K
Stock-based Comp 9-point trend, -73.6% $1M $1M $2M $4M $5M $10M $9M $8M $5M
Other Non-cash 4-point trend, -253.8% · · · · · $-45M $20M $29.4K $30M
Operating Cash Flow 9-point trend, -536.8% $-14M $-20M $-15M $-25M $-25M $-34M $-43M $-42M $3M
CapEx 2-point trend, -68.8% · · · $16.3K · · · · $52.4K
Investing Cash Flow 8-point trend, +100.0% $0 $0 $0 $-16.3K · $25M $14M $69M $-107M
Stock Repurchased · · · · · · · · $389
Net Stock Activity · · · · · · · · $-389
Financing Cash Flow 8-point trend, +57.8% $74M · $20M $-5 $60M $13M $525.0K $-3M $47M
Net Change in Cash 9-point trend, +207.0% $61M $-20M $5M $-25M $35M $4M $-29M $24M $-57M
Taxes Paid Flat — no change across 2 periods $0 $0 · · · · · · ·
Free Cash Flow · · · · · · · · $3M
Kârlılık 7
NERV için Yıllık Kârlılık verileri
Metrik Eğilim 202520242023202220212020201920182017
Operating Margin · · · · · 4.5% · · ·
Net Margin · · · · · 4.7% · · ·
Pretax Margin · · · · · 4.7% · · ·
EBITDA Margin · · · · · 4.5% · · ·
ROA 6-point trend, -2081.5% -434.3% · · · -74.1% 2.9% -66.6% -31.1% -19.9%
ROE 6-point trend, +1509.9% 339.5% · · · -276.8% 3.5% -173.3% -52.3% -24.1%
ROIC 4-point trend, -2245.0% · · · · -549.0% · -264.8% -57.3% -23.4%
Likidite ve Solventlik 3
NERV için Yıllık Likidite ve Solventlik verileri
Metrik Eğilim 202520242023202220212020201920182017
Current Ratio 6-point trend, +91.5% 36.3 · · · 22.1 8.7 7.1 24.9 18.9
Quick Ratio 6-point trend, +91.7% 35.9 · · · 21.6 8.0 6.9 24.4 18.7
Debt / Equity · · · · · · · · 0.0
Verimlilik 1
NERV için Yıllık Verimlilik verileri
Metrik Eğilim 202520242023202220212020201920182017
Asset Turnover 4-point trend, +0.61 · · · · · 0.6 0.0 0.0 0.0
Hisse Başına 5
NERV için Yıllık Hisse Başına verileri
Metrik Eğilim 202520242023202220212020201920182017
Book Value / Share 6-point trend, -195.8% $-3.25 · · · $0.19 $1.23 $0.71 $2.32 $3.40
Revenue / Share · · · · · $1.01 · · ·
Cash Flow / Share 3-point trend, -93.1% $-1.60 · · · $-0.58 $-0.83 · · ·
Cash / Share 6-point trend, +182.9% $1.90 · · · $1.42 $0.59 $0.55 $1.29 $0.67
EPS (TTM) 7-point trend, -1774.1% $-34.67 $0.19 $-4.61 $-6.01 $-9.35 $0.05 $-1.85 · ·
Değerleme (TTM) 13
NERV için Yıllık Değerleme (TTM) verileri
Metrik Eğilim 202520242023202220212020201920182017
Revenue TTM 7-point trend, +0.00 · $0 $0 $0 · $41M $0 $0 $0
Net Income TTM 9-point trend, -830.8% $-293M $1M $-30M $-32M $-50M $2M $-72M $-50M $-32M
Market Cap 6-point trend, -90.7% $174M · · · $274M $800M $2.22B $2.10B $1.88B
Enterprise Value · · · · · · · · $1.75B
P/E 7-point trend, +99.6% -0.1 11.7 -1.3 -0.3 -0.7 374.4 -30.7 · ·
P/S · · · · · 19.4 · · ·
P/B 6-point trend, -108.7% -1.2 · · · 34.3 15.2 80.0 23.3 14.3
P / Tangible Book · · · · · 35.4 · · ·
P / Cash Flow 6-point trend, -102.1% -12.9 · · · -11.1 -23.6 -51.2 -50.1 606.4
P / FCF · · · · · · · · 616.8
EV / EBITDA · · · · · · · · -42.5
EV / FCF · · · · · · · · 576.0
Earnings Yield 7-point trend, -26436.6% -862.4% 8.6% -75.0% -378.0% -145.9% 0.27% -3.2% · ·

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Gelir Tablosu
2025-12-312024-12-312023-12-312022-12-312021-12-31
Gelir $0$0$0
Net Gelir $-293M$1M$-30M$-32M$-50M
Seyreltilmiş Hisse Başı Kâr $-34.67$0.19$-4.61$-6.01$-9.35
Bilanço
2025-12-312024-12-312023-12-312022-12-312021-12-31
Cari Oran 36.322.1
Cari Oran 35.921.6

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

📊

Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.